MarketScreener Editorial Features BridgeBio Pharma, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:10:22 2026-03-13 pm EDT			5-day change	1st Jan Change
68.56 ^USD	+0.85%		+4.78%	-10.47%

Mar. 11	Bridgebio Pharma, Inc. Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9	CI
Mar. 11	BridgeBio Pharma plans to submit NDA for BBP-418 to FDA in H1 2026	RE

	Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead…	February 25, 2026 at 06:20 am EST
	Still Standing, Slightly Wobbly	October 30, 2025 at 09:53 am EDT
	Analyst recommendations: Boeing, Alphabet, Caterpillar, Chipotle, Wayfair…	October 30, 2025 at 06:23 am EDT
	The new silk road of optimism	October 27, 2025 at 10:22 am EDT
	Wall Street Bets Against Chaos, Again	September 29, 2025 at 09:12 am EDT
	In wait-and-see mode before Tesla and Netflix	July 17, 2023 at 09:43 am EDT
	Global markets live: First Citizens, Adidas, Apple, Standard Chartered JetBlue...	March 27, 2023 at 12:12 pm EDT